Found 6 matching trials
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PHASE1The primary objective of this study is to evaluate the safety and clinical ...
Location
Xunyang Changchun Shihua Hospital
A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer
N/AWe plan to enroll 20-29 patients with advanced bladder cancer to undergo T-...
Location
Multiple Locations
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
PHASE1This is a Phase 1, single-arm, single-center, open-label study to evaluate ...
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
PHASE1The purpose of the alloSHRINK study is to assess the safety, cell kinetics ...
Location
Moffit Cancer Center
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
PHASE1The purpose of the CYAD-101-002 study is to assess the safety and clinical ...
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PHASE1The primary objective of this study is to evaluate the safety and clinical ...
Location
Affiliated hospital of jiujiang university